Peter Wirth is a businessperson who founded Lysosomal Therapeutics, Inc. and who has been at the head of 5 different companies. Mr. Wirth holds the position of Chairman at Forma Therapeutics Holdings, Inc., Chairman at FORMA Therapeutics, Inc. (a subsidiary of Forma Therapeutics Holdings, Inc.) and Chairman for Syros Pharmaceuticals, Inc.
He is also on the board of Zai Lab Ltd.
In his past career he occupied the position of Executive Chairman at ZappRx, Inc., President & Director at Lysosomal Therapeutics, Inc., Head-Technology Group & Partner at Palmer & Dodge LLP and Secretary, EVP-Legal & Corporate Development at Genzyme Corp.
Peter Wirth received an undergraduate degree from the University of Wisconsin and a graduate degree from Harvard Law School.